Sign in to follow
Search Results

0 results for 'CVS Health'

You can use to get even better search results
September 10, 2010 |

2nd Circuit Declines En Banc Review of Drug 'Pay-to-Delay' Ruling

The 2nd Circuit has refused to reconsider en banc its holding that antitrust laws are not violated when drug patent holders pay manufacturers of generic alternatives to keep competing products off the market. The active members of the circuit issued a brief ruling Tuesday saying they had voted to deny rehearing en banc a case in which a three-judge panel in April affirmed summary judgment for Bayer AG on a Sherman Act challenge concerning a so-called "pay-for-delay" agreement involving the antibiotic drug Cipro.
5 minute read
In the Matters of Geraldine A., Respondents, D-16725/09
Publication Date: 2010-11-30
Practice Area: Juvenile Law
Industry:
Court: Family Court, Queens County
Judge: Judge John M. Hunt
Attorneys:
For plaintiff:
For defendant:
Case number: D-16725/09

Cite as: Matters of Geraldine A., D-16725/09, NYLJ 1202475438937, at *1 (Fam., QU, Decided November 23, 2010)Judge John M. HuntDecided: N

May 24, 2004 |

VERDICTS & SETTLEMENTS

Summaries of verdicts and settlements as reported in The National Law Journal.
5 minute read
May 31, 2007 |

King & Spalding Left Out of Longtime Client Coke's $4.1 Billion Deal

Industry observers have viewed Coca-Cola's purchase of Energy Brands and the Glaceau brand as Coke's embrace of the new world of vitamin-enhanced beverages. Coke may also be forging a new world among its transaction lawyers, as it tapped Skadden, Arps, Slate, Meagher & Flom instead of King & Spalding for the $4.1 billion cash deal. It's been called the biggest corporate acquisition in Coke's history, and the absence of King & Spalding is noticeable.
4 minute read
July 08, 2009 |

Justice Department Takes Stand Against 'Pay to Delay' Drug Deals

The practice is dubbed "pay to delay," or "reverse settlement." It happens when a brand-name drug company gives a generic challenger a lot of money, and the generic company agrees to keep its product off the market for a set number of years. These settlements are controversial but have been perfectly legal. Several federal appellate circuits have blessed the practice, and the DOJ under President Bush also supported it. But now, the Justice Department under President Obama is switching sides.
3 minute read
December 03, 2012 |

Class Action Filed Against Maker Of Generic Anticholesterol Drug

A putative class action has been lodged in New Jersey against the Princeton-based maker of the cholesterol-reducing drug Atorvastatin, which was found to be tainted with glass particles.
4 minute read
December 05, 2012 |

Class Action Filed Against Maker of Generic Anti-Cholesterol Drug

A putative class action has been lodged in New Jersey against the Princeton-based maker of the cholesterol-reducing drug Atorvastatin, which was found to be tainted with glass particles.
4 minute read
August 15, 2008 |

Premium Work

We researched the Fortune 100 to find out which law firms they used in 2007 in each of the following practice areas: corporate transactions, torts and negligence, commercial law and contracts litigation, employment and labor litigation, and intellectual property. Companies are listed in alphabetical order.
43 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • A Buyer's Guide to Law Firm Software

      Brought to you by PracticePanther

      Download Now

    • A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster

      Brought to you by HaystackID

      Download Now

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now